TMC targets 30% revenue contribution from fertility business


PETALING JAYA: TMC Life Sciences Bhd is targeting its fertility business to contribute 30% to the group’s revenue from the current 17% for the financial year ending June 2021 (FY21).

This revenue contribution growth will be partly driven by the group’s fertility centre in Puchong, which is expected to begin operations this May.

Speaking after TMC’s annual general meeting on Thursday, group CEO Wan Nadiah Wan Mohd Abdullah Yaakob said, “While the hospital business continues to be the group’s mainstream business, our fertility business is showing double-digit growth in revenue.

“Going forward, we expect the fertility business to grow faster than before.”

On Covid-19 effect on the group’s fertility business, Nadiah noted that there has been deferments and cancellations from its patients from China.

However, this is offset by local fertility patients and those from Indonesia.

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 1
Cxense type: free
User access status: 3

TMC Life Sciences

   

Did you find this article insightful?

Yes
No

Next In Business News

China banking regulator says property market is biggest 'grey rhino'
PBOC says China must prevent fiscal deficit monetisation
LBS Group reports stronger sequential performance in 3Q
Ringgit ends easier against US dollar at 4.0730
Super normal profit for Comfort Gloves as 3Q earnings surge over 1,000%
Eversendai posts 3Q net loss of RM35.8m
Mah Sing Group on track to achieve RM1.1b target
Trump to add China's SMIC and CNOOC to defence blacklist
KLCI slumps over 40 points in regional sell-off
Hong Kong stocks drop, but post best month in nearly 2 years

Stories You'll Enjoy